Symbols

BLRX

BioLineRx·NASDAQ

--(--)

BLRX Profile

Biolinerx Ltd.

A late clinical-stage biopharmaceutical company focused on oncology

Industry

Biological Technology

Established Date

Listing Date

07/25/2011

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.biolinerx.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

2 HaMa’ayan Street, Modi’in 7177871, Israel

Business

Late-stage clinical-stage biopharmaceutical companies.

Introduction

BioLineRx Ltd. Incorporated in April 2003 and commenced business. The company is a biopharmaceutical company specializing in oncology and rare diseases. Its first approved product, APHEXDA, was developed and commercialized through partnerships and adopted a growth strategy of introducing licensed assets in its focus areas.